These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 13827793)

  • 21. Relationship of the BCR gene breakpoint and the type of BCR/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia.
    Prejzner W
    Med Sci Monit; 2002 May; 8(5):BR193-7. PubMed ID: 12011769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genetic diagnosis of chronic myeloid leukemia].
    Kato C; Naoe T
    Nihon Rinsho; 2001 Dec; 59(12):2336-41. PubMed ID: 11766335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia.
    Ito Y; Shimamoto T; Kuriyama Y; Nakajima A; Sumi M; Watanabe Y; Beppu H; Ohtsubo K; Ohyashiki K
    Leukemia; 2002 May; 16(5):951-2. PubMed ID: 11986960
    [No Abstract]   [Full Text] [Related]  

  • 24. [Thromboelastographic investigations of blood coagulation during the menstrual cycle].
    NEGRINI AC; KOYUNCUOGLU H; CORREALE L
    Arch Maragliano Patol Clin; 1963 Apr; 19():187-206. PubMed ID: 13937936
    [No Abstract]   [Full Text] [Related]  

  • 25. Extramedullary BCR-ABL1-negative myeloid leukemia in a patient with chronic myeloid leukemia and synchronous cytogenetic abnormalities in Philadelphia-positive and -negative clones during imatinib therapy.
    Quintás-Cardama A; Kantarjian H; Abruzzo LV; Cortes J
    Leukemia; 2007 Nov; 21(11):2394-6. PubMed ID: 17690707
    [No Abstract]   [Full Text] [Related]  

  • 26. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
    Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
    N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
    Mittal P; Saliba RM; Giralt SA; Shahjahan M; Cohen AI; Karandish S; Onida F; Beran M; Champlin RE; de Lima M
    Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
    Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thromboelastographic findings in leukemia].
    FUMAROLA D; DEL BUONO G
    Prog Med (Napoli); 1957 Oct; 13(20):693-6. PubMed ID: 13505922
    [No Abstract]   [Full Text] [Related]  

  • 30. Novel tyrosine kinase inhibitors in chronic myelogenous leukemia.
    Jabbour E; Cortes J; Kantarjian H
    Curr Opin Oncol; 2006 Nov; 18(6):578-83. PubMed ID: 16988578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of leukemia-derived microparticles in the monitoring of chronic myeloid leukemia].
    Zhu X; Li Q; Zeng C; Zhong Z; You Y; Zou P
    Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):138-41. PubMed ID: 24606656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late appearance of a Philadelphia translocation with minor-BCR/ABL transcript in a t(7;11)(p15;p15) acute myeloid leukemia.
    Shimamoto T; Ohyashiki K; Ohyashiki JH; Fujimura T; Kodama A; Miyazawa K; Aizawa S; Toyama K
    Leukemia; 1995 Apr; 9(4):640-2. PubMed ID: 7723398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neutrophil function in hematologic disorders].
    Matzner Y
    Harefuah; 1991 Dec; 121(11):449-52. PubMed ID: 1786895
    [No Abstract]   [Full Text] [Related]  

  • 34. [Expressions of MIP-1alpha, MCP-1 and their receptors CCR-1, CCR-2 in chronic myeloid leukemia cells].
    Wang WL; Shen T; Hui YR; Gu XC; Li RS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):433-6. PubMed ID: 16800914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there an entity of chemically induced BCR-ABL-positive chronic myelogenous leukemia?
    Lichtman MA
    Oncologist; 2008 Jun; 13(6):645-54. PubMed ID: 18586919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chronic myelogenous leukemia in a girl].
    PALACIOS ; MINON R
    Rev Clin Esp; 1951 Jan; 40(2):124-5. PubMed ID: 14844922
    [No Abstract]   [Full Text] [Related]  

  • 37. BCR-ABL mutations in chronic myeloid leukemia.
    Ernst T; La Rosée P; Müller MC; Hochhaus A
    Hematol Oncol Clin North Am; 2011 Oct; 25(5):997-1008, v-vi. PubMed ID: 22054731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies.
    Clarkson B; Strife A; Wisniewski D; Lambek CL; Liu C
    Leukemia; 2003 Jul; 17(7):1211-62. PubMed ID: 12835715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic myeloid leukemia in hemophilia B].
    Larraín C
    Rev Med Chil; 2002 Aug; 130(8):897-900. PubMed ID: 12360799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.